Related Experiment Video
Updated: Jul 14, 2026

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
Influences on cognition by immunosuppression and immunomodulation in multiple sclerosis
Hayrettin Tumani1, Ingo Uttner
1Neurologische Klinik, Universität Ulm, Rehabilitationskrankenhaus, Oberer Eselsberg 45, 89081, Ulm, Germany. hayrettin.tumani@uni-ulm.de
Abstract:
Cognitive impairment is common also in early stages of MS, but only little is known about its relationship to standard immunotherapeutic drugs. Present data suggest that both immunosuppressive as well as immunomodulatory therapy prevent or delay the onset and severity of cognitive impairment although reversible cognitive deficits can occur.
Related Concept Videos
Multiple Sclerosis l: Introduction
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Psychoneuroimmunology: Diabetes and Cancer
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...

